Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Pension (2022 - 2023)

Historic Pension for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q2 2023 value amounting to $14969.9.

  • Neuphoria Therapeutics' Pension rose 9980.79% to $14969.9 in Q2 2023 from the same period last year, while for Jun 2023 it was $14969.9, marking a year-over-year increase of 9980.79%. This contributed to the annual value of $15083.2 for FY2023, which is 10131.94% up from last year.
  • According to the latest figures from Q2 2023, Neuphoria Therapeutics' Pension is $14969.9, which was up 9980.79% from $7492.2 recorded in Q2 2022.
  • In the past 5 years, Neuphoria Therapeutics' Pension registered a high of $14969.9 during Q2 2023, and its lowest value of $7492.2 during Q2 2022.